Merck and ENGC are in line for exits after Electrocore, the developer of a nerve stimulation treatment for headaches, filed to raise up to $74.8m.
Month: May 2018
GCV Symposium Day One: The transition of energy, mobility and travel
Tom Whitehouse, contributing editor of Global Corporate Venturing and chairman of the London Environmental Investment Forum, hosted the breakout session on the future of energy, mobility and travel during the first day of the eighth annual GCV Symposium in London yesterday. The session featured three speakers from corporate venture capital units involved in the broader… Continue reading GCV Symposium Day One: The transition of energy, mobility and travel
Foxconn writes down $200m Snapdeal investment
Foxconn subsidiary FIH Mobile has written down all but $3m of the $200m it provided for Snapdeal in 2015, according to its 2017 financial report.
Honor rolls to $50m series C
Naspers Ventures led the senior care provider’s latest round, investing alongside unnamed existing backers to increase its total funding to $115m.
Outreach reaps $65m reward in series D round
Existing investor Microsoft Ventures came back for a round that valued customer engagement platform Outreach at $500m and took its total funding to $125m.
Like licks series B with Ant Financial help
Chinese car rental service Like has followed up $20m in funding reportedly closed last month with an Ant Financial-led series B round.
DigiLens gets $25m in Continental investment
Strategic partner Continental has supplied $25m in series C funding for the optics technology developer, boosting its stake to 18%.
Raiffeisen offers startups a ride on its Elevator
The Austria-based bank has formed a $29.5m venture capital subsidiary called Elevator Ventures, adding to an existing accelerator initiative.
EIP secures Access for series B round
Diversified conglomerate Access Industries has led a $20.5m series B round for EIP Pharma, a US-based company developing treatments for diseases affecting the central nervous system (CNS). Founded in 2014, EIP is working on drugs for CNS disorders, and in particular a small molecule inhibitor called neflamapimod that could potentially reverse the synaptic impairment associated… Continue reading EIP secures Access for series B round
Cuebiq sticks landing on $27m series B
Nasdaq Ventures and DRW Venture Capital both invested in a round that will fund product development and international growth for location data provider Cuebiq.
Iora Health scores $100m
Existing investors GE Ventures and Humana both took part as the primary healthcare provider boosted its overall funding to more than $220m.
HMD gets its hands on $100m
HMD Global, which has licensed the rights to produce Nokia-developed phones, secured funding in a round featuring two Foxconn subsidiaries.
Grail holds another $300m for series C
WuXi AppTec took part in the cancer test developer’s latest round through WuXi NextCode and 6 Dimensions Capital, taking its total funding to more than $1.6bn.
Ant Financial to access $10bn
The Alibaba affiliate is raising funding from a range of institutional investors at a $150bn+ valuation, the largest ever by a private VC-backed company.